Scientific American features story on plasmalogens and Alzheimer’s disease

Prodrome Sciences is pleased to see recent media coverage of the important role plasmalogens play in Alzheimer’s disease. The Scientific American published an article on July 25, 2018, titled “A Gut – and Liver – Check to Get a Bead on Alzheimer’s” which reviews research results presented by Dr. Mitchel A. Kling, MD, on July 24 at the Alzheimer’s Association International Conference (AAIC) 2018. The July 24 AAIC presentation session titled “Gut-Liver-Brain Axis in Alzheimer’s Disease” included a presentation of recent research results where Dr. Dayan Goodenowe and Dr. Vijitha Senanyake of Prodrome Sciences are co-authors.

Dr. Dayan Goodenowe published his original findings linking plasmalogens with Alzheimer’s disease in a 2007 peer-reviewed research publication titled “Peripheral Ethanolamine Plasmalogen Deficiency: A Logical Causal Factor in Alzheimer’s Disease and Dementia”. Since that time, his research has led him to believe that plasmalogens play a large role in health and aging.

Prodrome Sciences is an integrated molecular diagnostics and therapeutics company focused on the early detection and prevention of disease. The Company uses its patented comprehensive metabolomics technology to discover prodromes of diseases; prodromes are states of biochemical imbalance that occur before disease symptoms appear. Prodrome Sciences develops blood tests to detect prodromes of diseases and therapeutics to restore unhealthy biochemical imbalances to a healthy state. The goal is to reduce the number of people that develop and die from disease and to promote optimal health and longevity.

Please contact us for more information.